|
Aug 5
|
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Tuesday; Palantir Technologies to Advance, Hims & Hers Health to Decline
|
|
Aug 5
|
The post-Figma question: Who’s next?
|
|
Aug 5
|
Trending tickers: Diageo, Palantir, Saudi Aramco, American Eagle and Hims & Hers
|
|
Aug 5
|
Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ...
|
|
Aug 4
|
IBD 50's Hims & Hers Plummets 9% On Second-Quarter Sales Miss
|
|
Aug 4
|
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
|
|
Aug 4
|
Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?
|
|
Aug 4
|
Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings
|
|
Aug 4
|
McDonald’s Earnings, New Tariff Deadline, PMIs: What to Watch This Week
|
|
Aug 3
|
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
|
|
Aug 3
|
Job market concerns take center stage as earnings season rolls on: What to watch this week
|
|
Aug 3
|
What To Expect From Hims & Hers Health’s (HIMS) Q2 Earnings
|
|
Aug 1
|
Earnings, Fed commentary, consumer credit: What to Watch
|
|
Aug 1
|
McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week
|
|
Aug 1
|
Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.
|
|
Aug 1
|
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
|
|
Aug 1
|
Palantir, AMD, Shopify Headline Another Busy Week of Tech Earnings
|
|
Aug 1
|
Healthcare Triangle Surges Forward: QuantumNexis's AI-Driven HIMS Platform 'Ezovion' Now Live on Microsoft Azure Marketplace
|
|
Aug 1
|
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
|
|
Jul 31
|
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
|